Cardinal Health Inc (CAH) Financial Statements

Analyzing Cardinal Health through the GoodMoat Quality Indicators reveals a business with major strengths and critical weaknesses. The 18.8% year-over-year revenue growth is a strong positive, suggesting robust demand and market positioning. However, the quality of this growth is questionable. The reported profit margin of 0.7% and operating margin of 1.0% are exceptionally low, failing to meet the framework's typical thresholds for high-quality businesses in any sector. This indicates a highly competitive, low-margin operation with minimal pricing power. Free cash flow generation, with a yield of 3.7%, is positive but modest, and without a stated FCF margin, it's difficult to assess its conversion efficiency from earnings. The balance sheet health is a concern; the provided Debt/Equity ratio is 'N/A', and the absence of a net cash position alongside a P/E of over 30x suggests the market is valuing the stock on growth rather than current earnings power, which is precarious given the razor-thin margins. For a value investor focused on durable returns on capital, the combination of weak profitability metrics and unclear balance sheet strength makes the financial quality unfavourable, despite the strong top-line growth. The business would likely score poorly on key Quality Indicators like Gross Margin, ROIC, and GAAP Profitability relative to the framework's benchmarks. Analysis based on data as of 2024-05-15.